Instil Bio, Inc.
- TIL
- NASDAQ
- Biotechnology
- TIL Cell Therapy
- Oncology Biotech
$6.14
Today +3.37%Quote Oct 21, 2026, 02:09 PM UTC
−15.98%over the last month
Max drawdown −20.0%From 1-month high −18.0%3 months −18.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Instil Bio
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
17
Founded
2018
Market value
$41.6M
Quote Oct 21
Floor
$5.67
7.7% below price
Resistance
$6.16
0.3% above price
Price vs analyst targets
8 analysts
Lowest target
$2.00Highest target
$120.00
$2.00Highest target
$120.00
- Price $6.14
- Average target $35.00
- Analysts' target range
The price is close to the lowest analyst target. Analysts' average target sits about 470% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TILPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free